{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:49:07Z","timestamp":1778888947882,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12350-019-01868-9","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T20:18:06Z","timestamp":1570479486000},"page":"1145-1153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Performance of 99mTc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy"],"prefix":"10.1016","volume":"27","author":[{"given":"Toru","family":"Awaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryogo","family":"Minamimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risen","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hiroi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Hiroe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Moroi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1007\/s12350-019-01868-9_bib1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: A comparison with light chain-associated amyloidosis","volume":"165","author":"Ng","year":"2005","journal-title":"Arch Intern Med."},{"issue":"19","key":"10.1007\/s12350-019-01868-9_bib2","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2011-10-388462","article-title":"Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival","volume":"119","author":"Venner","year":"2012","journal-title":"Blood."},{"issue":"9","key":"10.1007\/s12350-019-01868-9_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol."},{"issue":"4","key":"10.1007\/s12350-019-01868-9_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2017.1370421","article-title":"Attitudes about when and how to treat patients with AL amyloidosis: An international survey","volume":"24","author":"Milani","year":"2017","journal-title":"Amyloid."},{"issue":"2","key":"10.1007\/s12350-019-01868-9_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging."},{"issue":"3","key":"10.1007\/s12350-019-01868-9_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/13506120802193233","article-title":"Late enhancement in cardiac amyloidosis: Correlation of MRI enhancement pattern with histopathological findings","volume":"15","author":"Hosch","year":"2008","journal-title":"Amyloid."},{"issue":"6","key":"10.1007\/s12350-019-01868-9_bib7","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00380-015-0658-0","article-title":"Late gadolinium enhancement in cardiac amyloidosis: Attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia","volume":"31","author":"Hashimura","year":"2016","journal-title":"Heart Vessels."},{"issue":"12","key":"10.1007\/s12350-019-01868-9_bib8","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF01791147","article-title":"Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin","volume":"22","author":"Aprile","year":"1995","journal-title":"Eur J Nucl Med."},{"issue":"2","key":"10.1007\/s12350-019-01868-9_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"issue":"10","key":"10.1007\/s12350-019-01868-9_bib10","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation."},{"issue":"6","key":"10.1007\/s12350-019-01868-9_bib11","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0609.2007.00963.x","article-title":"Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis","volume":"79","author":"Han","year":"2007","journal-title":"Eur J Haematol."},{"issue":"3","key":"10.1007\/s12350-019-01868-9_bib12","first-page":"261","article-title":"Re-evaluating the potentials and limitations of (99m)Tc-aprotinin scintigraphy for amyloid imaging","volume":"3","author":"Minamimoto","year":"2013","journal-title":"Am J Nucl Med Mol Imaging."},{"issue":"8","key":"10.1007\/s12350-019-01868-9_bib13","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1046\/j.1432-1327.2000.01237.x","article-title":"Aprotinin binding to amyloid fibrils","volume":"267","author":"Cardoso","year":"2000","journal-title":"Eur J Biochem."},{"issue":"8","key":"10.1007\/s12350-019-01868-9_bib14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.nucmedbio.2005.06.006","article-title":"An improved (99m)Tc-aprotinin kit formulation: Quality control analysis of radiotracer stability and cold kit shelf life","volume":"32","author":"Smyth","year":"2005","journal-title":"Nucl Med Biol."},{"issue":"6","key":"10.1007\/s12350-019-01868-9_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00006231-200506000-00009","article-title":"Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin","volume":"26","author":"Sojan","year":"2005","journal-title":"Nucl Med Commun."},{"issue":"3","key":"10.1007\/s12350-019-01868-9_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s13139-015-0338-0","article-title":"Imaging findings and literature review of 18F-FDG PET\/CT in primary systemic AL amyloidosis","volume":"49","author":"Lee","year":"2015","journal-title":"Nucl Med Mol Imaging."},{"issue":"1","key":"10.1007\/s12350-019-01868-9_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Imaging."},{"issue":"12","key":"10.1007\/s12350-019-01868-9_bib18","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.recesp.2016.01.039","article-title":"Cardiac amyloidosis detected using (18)F-florbetapir PET\/CT","volume":"69","author":"Garcia-Gonzalez","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"issue":"4","key":"10.1007\/s12350-019-01868-9_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2004.10.028","article-title":"Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement","volume":"95","author":"Murtagh","year":"2005","journal-title":"Am J Cardiol."},{"issue":"3","key":"10.1007\/s12350-019-01868-9_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1253\/circj.CJ-15-0054","article-title":"Myocardial T1 mapping","volume":"79","author":"Bulluck","year":"2015","journal-title":"Circ J."},{"issue":"36","key":"10.1007\/s12350-019-01868-9_bib21","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: Impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1007\/s12350-019-01868-9_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm."},{"issue":"8 Pt 1","key":"10.1007\/s12350-019-01868-9_bib23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1460-9592.2001.01228.x","article-title":"Holter monitoring in AL amyloidosis: Prognostic implications","volume":"24","author":"Palladini","year":"2001","journal-title":"Pacing Clin Electrophysiol."}],"updated-by":[{"DOI":"10.1007\/s12350-020-02229-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000}}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01868-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-019-01868-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107135812301958X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107135812301958X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01868-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T21:10:01Z","timestamp":1716930601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107135812301958X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S107135812301958X"],"URL":"https:\/\/doi.org\/10.1007\/s12350-019-01868-9","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s12350-020-02229-7","asserted-by":"object"}]},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of 99mTc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-019-01868-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}